May 11, 2006 09:03 ET Posts Stock Pick List: Partnered With Increasing Revenues and Net Profits!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL -- (MARKET WIRE) -- May 11, 2006 -- names the following stocks to its Stock Pick List: Genesis Technology Group, Inc. (OTC BB: GTEC), JDSU (NASDAQ: JDSU),, Inc. (NASDAQ: BIDU), Movie Gallery, Inc. (NASDAQ: MOVI).

Genesis Technology Group, Inc. (OTC BB: GTEC) announced that Lotus Pharmaceuticals, Inc., its health care and pharmaceuticals partner in Beijing, has commenced programs to increase its 2006 revenues above $20 million with about 15% in net profits, to launch its new U.S. public corporation through a reverse merger, and to establish Lotus as a national brand in China. New facilities, manufacturing capability, and four drugs scheduled to come to market in the fall all contributed to the increased forecasts. Based on these revised projections and its significant equity stake in Lotus, Genesis estimates its own net gain could exceed $2 million.

At present, Lotus is undergoing an independent audit of its financial statements by a New York certified public accounting firm that will enable Genesis to create the publicly traded company, in which Genesis will have a percentage ownership, during this calendar year. Since March 2006, when Genesis Equity Partners acquired a significant interest in Lotus Pharmaceuticals, Inc., Lotus increased its revenues and profits forecasts by over 30% based on first quarter sales, exceeding $5 million.

Other stocks highlighted include JDSU (NASDAQ: JDSU): Stock Pick List, down 1% on 51 million shares,, Inc. (NASDAQ: BIDU): Stock Pick List, up 37% on 15 million shares, Movie Gallery, Inc. (NASDAQ: MOVI): Stock Pick List, down 2% on 1 million shares.

"Stocks have been hard-pressed to pick a direction in trading lately, going on a tear for a few days, only to see those gains wane in the next several sessions. The Dow Jones Industrial Average is, in fact, just now beginning to break out in the new year, still hovering slightly above the level it was at when the Federal Reserve began raising rates a year ago." More is available at:'s Daily Stock Updates:, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to

All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRG has been compensated one million restricted shares for GTEC. CRG has recieved additional compensation of ten thousand dollars, and has purchased two hundred ten thousand shares in the open market and has also received six hundred thousand common shares and four million four hundred thousand restricted shares as past compensation. CRG intends to sell its shares. CRG has sold approximately all but two million five hundred thousand restricted GTEC shares to date. CRG may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information